Top Page
Ayr Wellness
(OTC:AYR.A)
Ayr Wellness (AYR.A) vs. iShares MSCI Canada ETF (EWC)
Ayr Wellness Business Overview & Revenue Model
Ayr Wellness Earnings Call Summary
Ayr Wellness Financial Statement Overview
| Breakdown | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 |
|---|---|---|---|---|---|
Income Statement | |||||
| Total Revenue | 463.63M | 463.63M | 465.62M | 357.61M | 155.11M |
| Gross Profit | 176.68M | 202.44M | 190.44M | 138.10M | 103.10M |
| EBITDA | -154.53M | 84.60M | -67.66M | 87.69M | 17.21M |
| Net Income | -359.31M | -272.43M | -245.47M | -16.95M | -176.33M |
Balance Sheet | |||||
| Total Assets | 1.27B | 1.46B | 1.76B | 1.86B | 615.87M |
| Cash, Cash Equivalents and Short-Term Investments | 35.48M | 50.77M | 80.64M | 154.34M | 127.24M |
| Total Debt | 621.88M | 597.77M | 621.66M | 483.82M | 190.62M |
| Total Liabilities | 904.31M | 889.20M | 928.56M | 839.85M | 465.01M |
| Stockholders Equity | 379.53M | 581.78M | 833.32M | 1.02B | 150.86M |
Cash Flow | |||||
| Free Cash Flow | -15.14M | -12.44M | -96.66M | -127.78M | 21.74M |
| Operating Cash Flow | 9.63M | 27.16M | -34.16M | -27.78M | 36.51M |
| Investing Cash Flow | -21.81M | -24.15M | -66.50M | -219.63M | -62.25M |
| Financing Cash Flow | -3.10M | -32.89M | 26.96M | 274.51M | 144.57M |
Ayr Wellness Technical Analysis
Ayr Wellness Peers Comparison
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
| ― | $195.50M | 6.71 | 22.40% | ― | 27.24% | ― | |
| ― | C$298.20M | 74.00 | 1.86% | ― | 38.86% | ― | |
| ― | $7.86B | -0.30 | -43.30% | 2.27% | 22.53% | -2.21% | |
| ― | $31.56M | -3.59 | -19.58% | ― | 17.74% | 37.61% | |
| ― | $100.86M | -1.47 | -38.44% | ― | 18.62% | 52.09% | |
| ― | C$366.03M | -1.78 | -45.36% | ― | -12.25% | -47.36% | |
| ― | C$18.10M | ― | ― | ― | 0.63% | -31.86% |
Ayr Wellness Corporate Events
AYR Wellness has announced the commencement of Article 9 proceedings as part of its debt restructuring process with senior noteholders. This phase involves a foreclosure sale of certain assets and equity interests in specified subsidiaries across several states, scheduled for November 10, 2025. The company will continue operations and maintain product quality during the transition of asset ownership to the successful bidder. This restructuring step is crucial for AYR’s ongoing efforts to stabilize its financial standing and maintain cooperative relations with stakeholders.
The most recent analyst rating on ($TSE:AYR.A) stock is a Hold with a C$0.50 price target. To see the full list of analyst forecasts on Ayr Wellness stock, see the TSE:AYR.A Stock Forecast page.
Ayr Wellness Inc. is a vertically integrated cannabis multi-state operator in the United States, focusing on cultivation, manufacturing, and retailing of cannabis products. The company recently released its earnings report for the first quarter of 2025, highlighting a challenging financial period. Ayr Wellness reported a net loss of $57.1 million for the quarter, compared to a loss of $106.1 million in the same period last year. Revenues decreased to $107.3 million from $118 million, reflecting a decline in sales. The company faced increased operating expenses, including a $7.3 million impairment of assets, contributing to a loss from operations of $28.2 million. Despite the financial challenges, Ayr Wellness is focusing on strategic initiatives to improve its financial position. The company is actively working on cost-saving measures, optimizing efficiency, and exploring new market opportunities. Additionally, Ayr Wellness is restructuring its operations, including the sale of non-core assets, to focus on its core competencies in vertically integrated markets. Looking ahead, Ayr Wellness remains committed to executing its business plans and addressing financial challenges. The management is optimistic about mitigating the substantial doubt regarding its ability to continue as a going concern through strategic initiatives and potential financing opportunities.
AYR Wellness has announced the filing of its unaudited interim financial statements and Management’s Discussion and Analysis (MD&A) for the first quarter of 2025. These documents, available on SEDAR+ and the SEC’s EDGAR system, offer insights into the company’s operating performance and liquidity position. The release emphasizes the use of non-GAAP measures like Adjusted EBITDA and Adjusted Gross Profit to provide greater transparency and understanding of the company’s financial health, which may be beneficial for investors and stakeholders.
The most recent analyst rating on ($TSE:AYR.A) stock is a Hold with a C$0.50 price target. To see the full list of analyst forecasts on Ayr Wellness stock, see the TSE:AYR.A Stock Forecast page.
AYR Wellness Inc. has executed a senior secured bridge credit agreement to secure up to $50 million in funding. This agreement is part of AYR’s ongoing restructuring efforts to support operations, transition its core business, and preserve asset value, with implications for stakeholders and the company’s future positioning in the cannabis industry.
The most recent analyst rating on ($TSE:AYR.A) stock is a Hold with a C$0.50 price target. To see the full list of analyst forecasts on Ayr Wellness stock, see the TSE:AYR.A Stock Forecast page.
AYR Wellness has entered into a Restructuring Support Agreement with its senior noteholders to ensure the continued operation and transition of its core business under new ownership. The agreement includes an asset sale transaction and a bridge facility to provide liquidity for ongoing operations, with senior noteholders receiving new equity interests in the post-sale entity.
The most recent analyst rating on ($TSE:AYR.A) stock is a Buy with a C$3.50 price target. To see the full list of analyst forecasts on Ayr Wellness stock, see the TSE:AYR.A Stock Forecast page.
AYR Wellness has announced an extension of its Limited Waiver Agreement with the majority of its senior noteholders, pushing the temporary waiver period to July 29, 2025. This extension allows AYR to continue its operations without the immediate threat of default-related actions, as it addresses delays in financial filings and payment defaults, while also exploring growth opportunities in key markets.
The most recent analyst rating on ($TSE:AYR.A) stock is a Buy with a C$3.50 price target. To see the full list of analyst forecasts on Ayr Wellness stock, see the TSE:AYR.A Stock Forecast page.